Answer
Cryptococcus neoformans India ink CSF preparation encapsulated yeast

This diagnostic micrograph shows Cryptococcus neoformans in a cerebrospinal fluid (CSF) specimen using an India ink preparation at 400x magnification. The image displays classic negative staining where the dark carbon particles of the ink are excluded by the thick polysaccharide capsules of the yeast. This creates a highly characteristic 'halo' or clear zone surrounding the individual round-to-oval fungal cells against a dark, opaque background. Several yeast cells demonstrate size variation and internal morphology, including central dark cores or concentric ring-like structures. This visual finding is pathognomonic for cryptococcal meningitis in the appropriate clinical context, demonstrating the encapsulated nature of the fungal spores. The distribution pattern shows scattered individual cells and occasional budding forms, which are essential for identifying the yeast’s reproductive activity. This imaging modality is a critical rapid diagnostic tool in medical microbiology for identifying fungal infections in immunocompromised patients.

This composite figure illustrates the radiological and microbiological findings of a cerebral cryptococcal infection. Panels A-C show axial, coronal, and sagittal postcontrast T1-weighted MR images revealing a large, centrally located mass in the corpus callosum exhibiting prominent rim enhancement and surrounding vasogenic edema. Panel D is an initial diffusion-weighted image (DWI) showing rim hyperintensity without internal restricted diffusion, a finding that can distinguish this from a typical pyogenic brain abscess. Panels E-G demonstrate significant lesion regression and reduced enhancement 42 days after corticosteroid therapy, illustrating the potentially misleading radiological response of infectious pseudotumors to anti-inflammatory treatment. Panel H shows a subsequent DWI (70 days post-initial imaging) revealing new, multiple punctate hyperintense foci in the centrum semiovale, indicating disease progression and dissemination. Panel I is a cerebrospinal fluid (CSF) microscopy image using India ink stain, identifying the presence of encapsulated Cryptococcus neoformans yeast cells characterized by clear halos against the dark background. This sequence highlights the diagnostic challenge of differentiating fungal masses from neoplastic or demyelinating lesions.

A multi-panel figure illustrating diagnostic findings for neurocryptococcosis. Panels A, B, and C are axial T1-weighted post-contrast brain MRI scans. Panel A shows a right frontal, extra-axial, pseudo-meningiomatous lesion with homogeneous contrast enhancement. Panel B demonstrates diffuse, linear meningeal enhancement consistent with meningitis. Panel C, a follow-up MRI, reveals the progression of the right frontal lesion into an annular (ring-enhancing) structure, accompanied by significant ventricular enlargement indicating secondary hydrocephalus. Panel D is a cerebrospinal fluid (CSF) microscopy image using an India ink preparation. It shows characteristic encapsulated yeasts, identified as Cryptococcus neoformans, which appear as round, budding cells surrounded by a distinct clear halo (the capsule) that excludes the dark ink particles in the background. This composite image serves as an educational resource for identifying the neuroimaging manifestations and laboratory diagnosis of fungal central nervous system infections.

| Phase | Duration | Drug(s) |
|---|---|---|
| Induction | 2 weeks (minimum) | Liposomal Amphotericin B + Flucytosine (5-FC) |
| Consolidation | 8 weeks | Fluconazole 400 mg/day |
| Maintenance | ≥1 year | Fluconazole 200 mg/day |